The group’s principal activities include acquiring, developing and marketing pharmaceuticals products. The group acquired the products Indocin(R) and Aldomet(R) from Merck & Company, Inc. The group operates from the United States.
Executive Information
Name
Title
Email
John Vavricka
CEO, Pres.
N/A
Fred Krieger
CFO
N/A
Humphrey Harte
VP - Commercial Operations, Europe
N/A
Michael Spector
VP - Commercial Operations, North America, International
